Search - Université de Rennes Access content directly

Filter your results

12 Results
authIdHal_s : sophie-laffont

Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.

Arnaud Dieudonné , Etienne Garin , Sophie Laffont , Yan Rolland , Rachida Lebtahi et al.
Journal of Nuclear Medicine, 2011, 52 (12), pp.1930-7. ⟨10.2967/jnumed.111.095232⟩
Journal articles hal-00739517v1

Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres.

Etienne Garin , Laurence Lenoir , Yan Rolland , Sophie Laffont , Marc Pracht et al.
Nuclear Medicine Communications, 2011, 32 (12), pp.1245-55. ⟨10.1097/MNM.0b013e32834a716b⟩
Journal articles hal-00739618v1

Personalized Dosimetry with Intensification Using 90Y-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.

Etienne Garin , Yan Rolland , Julien Edeline , Nicolas Icard , Laurence Lenoir et al.
Journal of Nuclear Medicine, 2015, 56 (3), pp.339-46. ⟨10.2967/jnumed.114.145177⟩
Journal articles hal-01128116v1

Occupational radiation exposure of medical staff performing (90)Y-loaded microsphere radioembolization

Sophie Laffont , Yan Rolland , Valérie Ardisson , Julien Edeline , Marc Pracht et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 (5), pp.824-831. ⟨10.1007/s00259-015-3277-1⟩
Journal articles hal-01255872v1
Image document

High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90) Y-loaded glass microsphere radioembolization

Etienne Garin , Yan Rolland , Marc Pracht , Samuel Le Sourd , Sophie Laffont et al.
Liver International, 2017, 37 (1), pp.101-110. ⟨10.1111/liv.13220⟩
Journal articles hal-01447063v1
Image document

Utility of Quantitative Tc-MAA SPECT/CT for yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach.

Etienne Garin , Yan Rolland , Laurence Lenoir , Marc Pracht , Habiba Mesbah et al.
International Journal of Molecular Medicine, 2011, 2011, pp.398051. ⟨10.1155/2011/398051⟩
Journal articles hal-00739649v1

Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.

Etienne Garin , Laurence Lenoir , Yan Rolland , Julien Edeline , Habiba Mesbah et al.
Journal of Nuclear Medicine, 2012, 53 (2), pp.255-63. ⟨10.2967/jnumed.111.094235⟩
Journal articles hal-00866987v1

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation.

Etienne Garin , Yan Rolland , Eveline Boucher , Valérie Ardisson , Sophie Laffont et al.
European Journal of Nuclear Medicine, 2010, 37 (3), pp.453-61. ⟨10.1007/s00259-009-1279-6⟩
Journal articles istex hal-00742174v1
Image document

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Etienne Garin , Lambros Tselikas , Boris Guiu , Julia Chalaye , Julien Edeline et al.
The Lancet Gastroenterology & Hepatology, 2021, 6 (1), pp.17-29. ⟨10.1016/S2468-1253(20)30290-9⟩
Journal articles hal-02998830v1
Image document

Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma

Xavier Palard , Julien Edeline , Yan Rolland , Samuel Le Sourd , Marc Pracht et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 (3), pp.392-401. ⟨10.1007/s00259-017-3845-7⟩
Journal articles hal-01709935v1

Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.

Nicolas Lepareur , Sophie Laffont , Valérie Ardisson , Nicolas Noiret , Etienne Garin et al.
Nuclear Medicine Communications, 2012, 33 (2), pp.205-8. ⟨10.1097/MNM.0b013e32834e7580⟩
Journal articles hal-00867028v1
Image document

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres

Etienne Garin , Yan Rolland , Sophie Laffont , Julien Edeline
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 (3), pp.559-575. ⟨10.1007/s00259-015-3157-8⟩
Journal articles hal-01197349v1